EKF Diagnostics (LON:EKF) Shares Cross Below Two Hundred Day Moving Average – What’s Next?

EKF Diagnostics Holdings plc (LON:EKF) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 25.52 and traded as low as GBX 24.10. EKF Diagnostics shares last traded at GBX 24.60, with a volume of 471,151 shares trading hands.

Wall Street Analyst Weigh In

Separately, Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 35 price target on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of GBX 35.

EKF Diagnostics Trading Down 0.4%

The stock has a fifty day simple moving average of GBX 25.80 and a 200 day simple moving average of GBX 25.51. The company has a quick ratio of 1.77, a current ratio of 4.16 and a debt-to-equity ratio of 2.01. The firm has a market capitalization of £107.49 million, a P/E ratio of 53.19 and a beta of 0.50.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.